Masterplan for the promotion of biomedical research and technology

Switzerland has a very good international position in biomedical research and technology. To make sure this remains the case, in 2013 the Federal Council launched a master plan to further boost this sector. 

International competition in biomedical research and technology is expected to increase over the coming years. In response to requests from parliament, in 2013 the Federal Council presented a package of measures designed to boost Switzerland as a centre of biomedical research and technology going forward.

The master plan, based on the strategic objectives in the 2011-15 legislature planning report and the Federal Council’s Health2020 agenda, is designed to facilitate a cross-sectoral approach. Measures which have already been decided on can be coordinated with measures under revision or being planned.

The overarching goal of the master plan is to maintain and develop as good a framework as possible for biomedical research and technology, and at the same time to enable people in Switzerland to physically benefit from the achievements of biomedicine and give them affordable access to the latest biomedical products.

An interdepartmental working group headed by the Federal Office of Public Health FOPH is guiding implementation of the plan.

Measures

The master plan initially comprises 21 measures covering education/training and continuing education, market entry and oversight, reimbursement by social security, orphan (rare) diseases and intellectual property. In 2016 two additional measures covering security of supply and medical devices were added. Various departments of the FOPH, the State Secretariat for Education, Research and Innovation SERI and Swissmedic, the Swiss agency for the authorisation and supervision of therapeutic products, are responsible for the measures.

Interim reporting

The Federal Council makes regular progress reports on the implementation of the various measures. The 2017 interim report revealed progress in all areas covered by the master plan. The table shows the status of implementation and the degree to which targets have been attained for all 23 measures.

In 2018, the Federal Council will draw up an interim balance of the measures taken to date and decide on further action.

Press releases

Java script is required to display press releases. If you are unable or unwilling to activate Java script you may use the link below to access the Federal Administration News Portal, where you can read the announcements.

To the Federal Administration News Portal

Java script is required to display press releases. If you are unable or unwilling to activate Java script you may use the link below to access the Federal Administration News Portal, where you can read the announcements.

To the Federal Administration News Portal

Last modification 14.08.2017

Top of page

Contact

Federal Office of Public Health FOPH
Division of Biomedicine
CH - 3003 Bern

Tel.
+41 58 463 51 54

E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/themen/mensch-gesundheit/biomedizin-forschung/biomedizinische-forschung-und-technologie/masterplan-zur-staerkung-der-biomedizinischen-forschung-und-technologie.html